Plasma sphingosine 1-phosphate levels and the risk of vertebral fracture in postmenopausal women

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 10, 2012, Pages 3807-3814

  Kim, Beom Jun ^a   Koh, Jung Min ^a   Lee, Sun Young ^b   Lee, Young Sun ^b   Lee, Seung Hun ^a   Lim, Kyeong Hye ^a   Cho, Eun Hee ^c   Kim, Sang Wook ^c   Kim, Tae Ho ^d   Kim, Shin Yoon ^d,e   Kim, Ghi Su ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Institute for Life Sciences   (South Korea)

^c Kangwon National University College of Medicine   (South Korea)

^d Kyungpook National University Hospital   (South Korea)

^e Kyungpook National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; SPHINGOSINE 1 PHOSPHATE;

AGED; ARTICLE; BODY MASS; BONE DENSITY; BONE RADIOGRAPHY; BONE TURNOVER; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; KOREA; MAJOR CLINICAL STUDY; OSTEOLYSIS; POSTMENOPAUSE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SPINE FRACTURE; THORACOLUMBAR SPINE;

AGED; BONE DENSITY; CASE-CONTROL STUDIES; FEMALE; HUMANS; LUMBAR VERTEBRAE; LYSOPHOSPHOLIPIDS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SPHINGOSINE; SPINAL FRACTURES; THORACIC VERTEBRAE;

EID: 84867255636     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2346     Document Type: Article

References (31)

1. Melton LJ 1993 Hip fractures: a worldwide problem today and tomorrow. Bone 14(Suppl 1):S1-S8
2. Cooper C, Atkinson EJ, Jacobsen SJ, O'Fallon WM, Melton 3rd LJ 1993 Population-based study of survival after osteoporotic fractures. Am J Epidemiol 137:1001-1005 (Pubitemid 23191067)
3. Wainwright SA, Marshall LM, Ensrud KE, Cauley JA, Black DM, Hillier TA, Hochberg MC, Vogt MT, Orwoll ES 2005 Hip fracture in women without osteoporosis. J Clin Endocrinol Metab 90:2787-2793 (Pubitemid 40686325)
4. Sanders KM, Nicholson GC, Watts JJ, Pasco JA, Henry MJ, Kotowicz MA, Seeman E 2006 Half the burden of fragility fractures in the community occur in women without osteoporosis. When is fracture prevention cost-effective? Bone 38:694-700
5. 1994 Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 843:1-129
6. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E 2008 FRAXand the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385-397
7. Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A 2008 Case finding for the management of osteoporosis with FRAX-assessment and intervention thresholds for the UK. Osteoporos Int 19:1395-1408
8. Trémollieres FA, Pouillès JM, Drewniak N, Laparra J, Ribot CA, Dargent-Molina P 2010 Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool. J Bone Miner Res 25:1002-1009
9. Bolland MJ, Siu AT, Mason BH, Horne AM, Ames RW, Grey AB, Gamble GD, Reid IR 2011 Evaluation of the FRAX and Garvan fracture risk calculators in older women. J Bone Miner Res 26:420-427
10. Rosen H, Goetzl EJ 2005 Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat Rev Immunol 5:560-570 (Pubitemid 40961333)
11. Grey A, Xu X, Hill B, Watson M, Callon K, Reid IR, Cornish J 2004 Osteoblastic cells express phospholipid receptors and phosphatases and proliferate in response to sphingosine-1-phosphate. Calcif Tissue Int 74:542-550 (Pubitemid 38780290)
12. Ishii M, Egen JG, Klauschen F, Meier-Schellersheim M, Saeki Y, Vacher J, Proia RL, Germain RN 2009 Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature 458:524-528
13. Grey A, Chen Q, Callon K, Xu X, Reid IR, Cornish J 2002 The phospholipids sphingosine-1-phosphate and lysophosphatidic acid prevent apoptosis in osteoblastic cells via a signaling pathway involving G(i) proteins and phosphatidylinositol-3 kinase. Endocrinology 143:4755-4763 (Pubitemid 35397617)
14. Roelofsen T, Akkers R, Beumer W, Apotheker M, Steeghs I, van de Ven J, Gelderblom C, Garritsen A, Dechering K 2008 Sphingosine-1-phosphate acts as a developmental stage specific inhibitor of plate-let- derived growth factor-induced chemotaxis of osteoblasts. J Cell Biochem 105:1128-1138
15. Ryu J, Kim HJ, Chang EJ, Huang H, Banno Y, Kim HH 2006 Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling. EMBO J 25:5840-5851 (Pubitemid 44967767)
16. Ishii M, Kikuta J, Shimazu Y, Meier-Schellersheim M, Germain RN 2010 Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo. J Exp Med 207:2793-2798
17. Maeda Y, Seki N, Sato N, Sugahara K, Chiba K 2010 Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow. Int Immunol 22:515-525
18. Peest U, Sensken SC, Andréani P, Hanel P, Van Veldhoven PP, Gräler MH 2008 S1P-lyase independent clearance of extracellular sphingosine 1-phosphate after dephosphorylation and cellular uptake. J Cell Biochem 104:756-772 (Pubitemid 351830827)
19. Zhao Y, Kalari SK, Usatyuk PV, Gorshkova I, He D, Watkins T, Brindley DN, Sun C, Bittman R, Garcia JG, Berdyshev EV, Natarajan V 2007 Intracellular generation of sphingosine 1-phosphate in human lung endothelial cells: role of lipid phosphate phosphatase-1 and sphingosine kinase 1. J Biol Chem 282:14165-14177 (Pubitemid 47100473)
20. Kiel D 1995 Assessing vertebral fractures. National Osteoporosis Foundation Working Group on Vertebral Fractures. J Bone Miner Res 10:518-523
21. Genant HK, Wu CY, van Kuijk C, Nevitt MC 1993 Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137-1148 (Pubitemid 23261108)
22. Lai WQ, Irwan AW, Goh HH, Howe HS, Yu DT, Valle-Oñate R, McInnes IB, Melendez AJ, Leung BP 2008 Anti-inflammatory effects of sphingosine kinase modulation in inflammatory arthritis. J Immunol 181:8010-8017
23. Pederson L, Ruan M, Westendorf JJ, Khosla S, Oursler MJ 2008 Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc Natl Acad Sci USA 105:20764-20769
24. Lee SH, Lee SY, Lee YS, Kim BJ, Lim KH, Cho EH, Kim SW, Koh JM, Kim GS 7 June 2012 Higher circulating sphingosine 1-phosphate levels are associated with lower bone mineral density and higher bone resorption marker in humans. J Clin Endocrinol Metab 10.1210/j.c.2012-1044
25. Eastell R, Robins SP, Colwell T, Assiri AM, Riggs BL, Russell RG 1993 Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption. Osteoporos Int 3:255-260 (Pubitemid 23252444)
26. Parfitt AM, Mathews CH, Villanueva AR, Kleerekoper M, Frame B, Rao DS 1983 Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest 72:1396-1409 (Pubitemid 13013772)
27. Seeman E 2002 Pathogenesis of bone fragility in women and men. Lancet 359:1841-1850 (Pubitemid 34607063)
28. Borah B, Dufresne TE, Chmielewski PA, Johnson TD, Chines A, Manhart MD 2004 Risedronate preserves bone architecture in post-menopausal women with osteoporosis as measured by three-dimensional microcomputed tomography. Bone 34:736-746 (Pubitemid 38393811)
29. Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD 2000 Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res 15:1526-1536 (Pubitemid 30484522)
30. Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Bréart G, Meunier PJ, Delmas PD 1996 Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. J Bone Miner Res 11:1531-1538 (Pubitemid 26331009)
31. Rivera J, Proia RL, Olivera A 2008 The alliance of sphingosine-1- phosphate and its receptors in immunity. Nat Rev Immunol 8:753-763